Akorn, Inc. (AKRX) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
1925 W. FIELD COURT, SUITE 300 LAKE FOREST, IL 60045 |
| State of Incorp. | LA |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 6/30/2020 Q2 | 3/31/2020 Q1 | 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 72,181 | 205,542 | 178,264 | 184,090 | 224,868 | ||||
| Cash and cash equivalent | 72,181 | 205,542 | 178,264 | 184,090 | 224,868 | ||||
| Receivables | 187,218 | 142,871 | 172,611 | 174,325 | 153,126 | ||||
| Inventory, net of allowances, customer advances and progress billings | 172,597 | 167,701 | 162,593 | 162,752 | 173,645 | ||||
| Inventory | 172,597 | 167,701 | 162,593 | 162,752 | 173,645 | ||||
| Other undisclosed current assets | 58,868 | 17,842 | 24,307 | 29,286 | 32,180 | ||||
| Total current assets: | 490,864 | 533,956 | 537,775 | 550,453 | 583,819 | ||||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 21,982 | 23,016 | 22,542 | ✕ | |||||
| Property, plant and equipment | 294,499 | 334,853 | |||||||
| Intangible assets, net (including goodwill) | 209,659 | 511,849 | 521,224 | 531,567 | 568,855 | ||||
| Goodwill | 267,923 | 267,923 | 267,923 | 283,879 | |||||
| Intangible assets, net (excluding goodwill) | 209,659 | 243,926 | 253,301 | 263,644 | 284,976 | ||||
| Other noncurrent assets | 15,271 | 7,424 | 7,520 | 7,228 | 7,730 | ||||
| Other undisclosed noncurrent assets | 21,973 | ||||||||
| Total noncurrent assets: | 541,411 | 542,289 | 551,286 | 560,768 | 911,438 | ||||
| Other undisclosed assets | 322,119 | 325,098 | 325,970 | ||||||
| TOTAL ASSETS: | 1,032,275 | 1,398,364 | 1,414,159 | 1,437,191 | 1,495,257 | ||||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 75,212 | 94,484 | 85,063 | 81,594 | 74,857 | ||||
| Taxes payable | 181 | 165 | 13,955 | 13,925 | |||||
| Employee-related liabilities | 24,563 | 29,695 | 19,762 | 16,529 | 19,745 | ||||
| Accounts payable | 31,118 | 52,389 | 38,420 | 38,419 | 39,570 | ||||
| Accrued liabilities | 19,350 | 12,235 | 12,926 | 12,721 | 15,542 | ||||
| Debt | 856,048 | 840,870 | 830,774 | ||||||
| Other undisclosed current liabilities | 54,343 | 80,557 | 115,871 | 87,192 | 95,966 | ||||
| Total current liabilities: | 985,603 | 1,015,911 | 1,031,708 | 168,786 | 170,823 | ||||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 21,456 | 22,600 | 21,921 | 821,715 | 820,411 | ||||
| Long-term debt, excluding current maturities | 821,715 | 820,411 | |||||||
| Finance lease, liability | 29 | 38 | 44 | ✕ | |||||
| Liabilities, other than long-term debt | 13,579 | 10,483 | 60,922 | 58,931 | 59,591 | ||||
| Deferred income tax liabilities | 943 | 937 | ✕ | ||||||
| Liability for uncertainty in income taxes | 2,684 | 2,285 | 52,516 | 51,410 | 49,990 | ||||
| Liability, pension and other postretirement and postemployment benefits | 10,895 | 7,255 | 7,469 | 7,521 | |||||
| Other liabilities | 9,601 | ||||||||
| Operating lease, liability | 21,427 | 22,562 | 21,877 | ✕ | |||||
| Other undisclosed noncurrent liabilities | 31,131 | 36,962 | 38,456 | 22,010 | 566 | ||||
| Total noncurrent liabilities: | 66,166 | 70,045 | 121,299 | 902,656 | 880,568 | ||||
| Other undisclosed liabilities | |||||||||
| Total liabilities: | 1,051,769 | 1,085,956 | 1,153,007 | 1,071,442 | 1,051,391 | ||||
| Equity | |||||||||
| Equity, attributable to parent | (19,494) | 312,408 | 261,152 | 365,749 | 443,866 | ||||
| Common stock | 598,873 | 590,274 | 584,592 | 579,157 | 574,553 | ||||
| Accumulated other comprehensive loss | (27,702) | (24,588) | (22,492) | (24,059) | (23,519) | ||||
| Accumulated deficit | (590,665) | (253,278) | (300,948) | (189,349) | (107,168) | ||||
| Total equity: | (19,494) | 312,408 | 261,152 | 365,749 | 443,866 | ||||
| TOTAL LIABILITIES AND EQUITY: | 1,032,275 | 1,398,364 | 1,414,159 | 1,437,191 | 1,495,257 | ||||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 6/30/2020 Q2 | 3/31/2020 Q1 | 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 204,693 | (520,172) | 176,244 | 178,057 | 165,871 | 153,386 | ||
| Cost of revenue (Cost of Product and Service Sold) | (110,149) | (104,842) | (110,073) | (112,358) | (128,139) | |||
| Gross profit: | 94,544 | 71,402 | 67,984 | 53,513 | 25,247 | |||
| Operating expenses | (341,462) | (62,634) | (155,350) | (118,996) | (221,112) | |||
| Operating income (loss): | (246,918) | 8,768 | (87,366) | (65,483) | (195,865) | |||
| Nonoperating income (expense) | (33,254) | (27,355) | (22,751) | (15,278) | 37,621 | |||
| Interest and debt expense | (8,629) | (8,581) | (5,655) | (1,304) | (1,304) | |||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (45,900) | |||||||
| Loss from continuing operations before equity method investments, income taxes: | (288,801) | (27,168) | (115,772) | (82,065) | (205,448) | |||
| Other undisclosed income (loss) from continuing operations before income taxes | 8,629 | 8,581 | 5,655 | 1,304 | (3,912) | |||
| Loss from continuing operations before income taxes: | (280,172) | (18,587) | (110,117) | (80,761) | (209,360) | |||
| Income tax expense (benefit) | 23,445 | 66,257 | (1,482) | (1,420) | (5,678) | |||
| Income (loss) from continuing operations: | (256,727) | 47,670 | (111,599) | (82,181) | (215,038) | |||
| Income (loss) before gain (loss) on sale of properties: | (256,727) | 47,670 | (111,599) | (82,181) | (215,038) | |||
| Net income (loss) available to common stockholders, diluted: | (256,727) | 47,670 | (111,599) | (82,181) | (215,038) | |||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 6/30/2020 Q2 | 3/31/2020 Q1 | 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (256,727) | 47,670 | (111,599) | (82,181) | (215,038) | |||
| Other undisclosed comprehensive income | 19 | |||||||
| Comprehensive income (loss): | (256,727) | 47,670 | (111,599) | (82,181) | (215,019) | |||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (411) | (2,096) | 1,567 | (540) | 2,294 | |||
| Comprehensive income (loss), net of tax, attributable to parent: | (257,138) | 45,574 | (110,032) | (82,721) | (212,725) | |||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.